Clark Mitchall G. 4
4 · Atara Biotherapeutics, Inc. · Filed May 21, 2018
Insider Transaction Report
Form 4
Clark Mitchall G.
Chief R & QA Officer
Transactions
- Sale
Common Stock
2018-05-18$50.03/sh−25,860$1,293,776→ 107,972 total
Footnotes (2)
- [F1]Transaction pursuant to Rule 10b5-1 Plan adopted January 25, 2018.
- [F2]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $50.00 to $50.10. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.